SC slams cancer drug overpricing as 'daylight dacoity'

The Supreme Court expressed shock over an essential cancer drug priced at ₹27,000 while being supplied to retailers at ₹2,700, reflecting a 10-fold change in price. The bench called it "broad daylight dacoity" against patients and questioned why regulators remained silent. The matter is listed for further hearing on September 29.